Journey Forward: How Can We Make Survivorship Care Planning a Reality?
I recently attended the American College of Surgeons Commission on Cancer (CoC) Spring Meeting. The CoC membership includes Fellows of the American College of Surgeons, as well as representatives from 52 other member organizations. In 2010, NCCS became one of four patient advocacy organizations to serve as members of the ...
WCOE: Employment Issues, Health Systems, Defining Value in Cancer Care
What Caught Our Eye (WCOE) Each week, we take a closer look at the cancer policy articles, studies, and stories that caught our attention. “Many clinicians believe that although patients may miss work during treatment, they will ‘bounce back’ in the longer term. The results of this study suggest otherwise and ...
ACOs and Delivering Care for Older Adults: Two Recent Articles That Caught Our Attention
"What We Can Learn by Listening to Older Adults" Chris Langston, a program director at the John A. Hartford Foundation, penned a recent Prepared Patient Blog post that resides on the Center for Advancing Health (CFAH) website. It refers to what many of us have learned from our work in patient advocacy which points ...
NCCS Applauds Test of Care Choices for Cancer Patients
The National Coalition for Cancer Survivorship (NCCS) applauds the recent decision by Health and Human Services Secretary Kathleen Sebelius to initiate the Medicare Care Choices Model, a project to evaluate the impact of permitting Medicare patients to receive ongoing curative care while also receiving hospice care. “NCCS has focused its ...
NCCS CEO’s Article via CURE “Aiming to Improve Quality of Cancer Care”
In a recent article posted online via CURE Magazine, Shelley Fuld Nasso describes experiences that underscore the need for improved communication between patients and providers, as well as the evidence-base that informs NCCS' push for cancer care planning. The Institute of Medicine recently proposed a framework for quality cancer care ...
Oncology Times: NCCS-AEI Meeting Emphasizes Putting Cancer Patient First in Physician Payment Reform
A summary and overview of the recent "Putting the Cancer Patient First" meeting was posted via Oncology Times online. The meeting was co-hosted by NCCS and the American Enterprise Institute (AEI) on February 28, 2014 and convened leaders in health care policy to discuss issues that impact cancer patients and survivors. Read the summary >> The ...
NCCS/AEI Co-Hosted Event to Be Streamed Live
The National Coalition for Cancer Survivorship and the American Enterprise Institute (AEI) will co-host a symposium, “Putting the Cancer Patient First: Payment Reform in an Age of Personalized Cancer Care.” Friday, February 28, from 8:30 a.m. to 12:30 p.m. at the American Enterprise Institute Conference Center in Washington, DC. For those unable to ...
JAMA Article: Incorporating Patient Preferences in Practice Guidelines
An article published in the current issue of the Journal of the American Medical Association (JAMA) cites several challenges to the incorporation of patient preferences in decision-making and guideline-directed care. In The Optimal Practice of Evidence-Based Medicine: Incorporating Patient Preferences in Practice Guidelines, the Mayo Clinic-affiliated authors also discuss the complexity ...
NCCS Submits Comments in Follow-Up to FDA Patient-Focused Public Meeting
NCCS submitted comments to the Food and Drug Administration (FDA) as a follow-up to the Lung Cancer Patient-Focused Drug Development public meeting on June 28, 2013. The patient-focused drug development program is an initiative mandated by the Food and Drug Administration Safety and Innovation Act (FDASIA) and is intended to provide the ...
Shelley Fuld Nasso of NCCS Is Panelist at FDA Lung Cancer Meeting
Shelley Fuld Nasso, NCCS Senior Director of Policy, was a panelist at the June 28, 2013, Food and Drug Administration (FDA) meeting on patient-focused lung cancer drug development. Ms. Fuld Nasso offered advice to FDA about strategies for incorporating patient needs and preferences in lung cancer drug development. She concentrated ...
